Lupin launches Rufinamide Tablets USP in the US
Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Rufinamide tablets
Lupin receives US FDA approval for Rufinamide tablets
The product will be manufactured at Lupin’s facility in Goa
Glenmark launches Rufinamide Tablets USP, 200 mg and 400 mg
It is indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) along with other medicines
Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide tablets USP
Under the terms of a settlement agreement between Glenmark and Eisai, Glenmark will be permitted to market this product in the US…